Vitamin D Satus in Adults With Newly Diagnosed ITP
ConditionVitamin D Concentration
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-50
SponsorAssiut University
About this trial
Investigator study aims to assess the level of vitamin D in adult patients with newly diagnosed ITP and correlation between its level and treatment respose
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Adult patients (\>18 years), both male and female, with newly diagnosed immune thrombocytopenia (ITP), recruited from hematology clinics
Trial design
Design model
Case-control
Time perspective
Retrospective
Treatments tested in this trial
No Interventions
Other intervention
Treatment groups
84 Participants
are divided into 3 treatment groupsGroup A: First group is responder to ttt of ITP0 interventions
Group B: 3 groups and assess vitamin D level and its relation with bleeding severity and treatment response1 intervention
Group C: Second group is non responder to ttt of ITP0 interventions
Trial outcomes
Primary outcomes
1
Evaluation of Vitamin D Status in Adult Patients with Newly Diagnosed Immune Thrombocytopenia (ITP)
Time frame
Baseline to 3 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: